Modified human IGF-1R antibodies

Details for Australian Patent Application No. 2004265152 (hide)

Owner Pfizer Products Inc.

Inventors Cohen, Bruce David; Bedian, Vahe

Agent Allens Arthur Robinson

Pub. Number AU-A-2004265152

PCT Pub. Number WO2005/016967

Priority 60/495,200 13.08.03 US

Filing date 3 August 2004

Wipo publication date 24 February 2005

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/016967 Priority application(s): WO2005/016967

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004265159-Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei

2004265149-Aminopyrones and their use as ATM inhibitors